Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity

QR Code

Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Shunichi Taki, Kohei Matsuoka, Yuko Nishinaga, Kazuomi Takahashi, Hirotoshi Yasui, Chiaki Koike, Misae Shimizu, Mitsuo Sato, Kazuhide Sato
Format:	article
Langue:	EN
Publié:	BMJ Publishing Group 2021
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/6fce37aff25441e788d1e7a7cc1e0694
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Association between inflammatory cytokines and immune-checkpoint molecule in rheumatoid arthritis.
par: Haruki Matsumoto, et autres
Publié: (2021)

Association between inflammatory cytokines and immune–checkpoint molecule in rheumatoid arthritis
par: Haruki Matsumoto, et autres
Publié: (2021)

Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufficiency
par: Katsunori Manaka, et autres
Publié: (2021)

Enhancing mucosal immunity by transient microbiota depletion
par: Simone Becattini, et autres
Publié: (2020)

Indicators of responsiveness to immune checkpoint inhibitors
par: Bradley D. Shields, et autres
Publié: (2017)

Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer
par: Ryoichi Katsube, et autres
Publié: (2021)

Managing cardiotoxicity associated with immune checkpoint inhibitors
par: Sireesha Upadhrasta, et autres
Publié: (2019)

The roles of exosomal immune checkpoint proteins in tumors
par: Cheng Xing, et autres
Publié: (2021)

CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
par: A. V. Bogolyubova, et autres
Publié: (2015)

Immune-mediated adverse events in immune checkpoint inhibitors therapy: literature review
par: Marina A. Lyadova, et autres
Publié: (2021)

Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
par: Shawn T. Beug, et autres
Publié: (2017)

Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
par: Can Öztürk, et autres
Publié: (2021)

Evaluating the impact of age on immune checkpoint therapy biomarkers
par: Rossin Erbe, et autres
Publié: (2021)

Metabolomic adaptations and correlates of survival to immune checkpoint blockade
par: Haoxin Li, et autres
Publié: (2019)

A decade of immune-checkpoint inhibitors in cancer therapy
par: Caroline Robert
Publié: (2020)

Predictors of responses to immune checkpoint blockade in advanced melanoma
par: N. Jacquelot, et autres
Publié: (2017)

Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
par: Yaolin Xu, et autres
Publié: (2021)

Spatiotemporal dynamics of a glioma immune interaction model
par: Subhas Khajanchi, et autres
Publié: (2021)

CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma
par: Fangkun Liu, et autres
Publié: (2020)

Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
par: Zou W, et autres
Publié: (2021)

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
par: Nicola Personeni, et autres
Publié: (2021)

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
par: Katrin Aslan, et autres
Publié: (2020)

Immune checkpoint modulation enhances HIV-1 antibody induction
par: Todd Bradley, et autres
Publié: (2020)

Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
par: Zheng-Hang Wang, et autres
Publié: (2018)

Acute kidney injury in patients treated with immune checkpoint inhibitors
par: Enriqueta Felip, et autres
Publié: (2021)

Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
par: Kennedy Yao Yi Ng, et autres
Publié: (2021)

Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitors
par: Despina Michailidou, et autres
Publié: (2021)

Correction: Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
par: Shawn T. Beug, et autres
Publié: (2018)

Combination of Near-Infrared Photoimmunotherapy Using Trastuzumab and Small Protein Mimetic for HER2-Positive Breast Cancer
par: Haruka Yamaguchi, et autres
Publié: (2021)

Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis
par: Chie Miyabe, et autres
Publié: (2021)

Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
par: Jun Zhao, et autres
Publié: (2019)

Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
par: Di Wang, et autres
Publié: (2021)

Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
par: Pei-Yi Chu, et autres
Publié: (2021)

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
par: Andrew Haydon, et autres
Publié: (2021)

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
par: Ben‐Yuan Jiang, et autres
Publié: (2021)

Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
par: Zoe Apalla, et autres
Publié: (2021)

Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
par: Mirjana Efremova, et autres
Publié: (2018)

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
par: Xin Cai, et autres
Publié: (2021)

Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
par: Yingyan Yu
Publié: (2021)

Progress of Immune Checkpoint Inhibitors  in the Treatment of Advanced Pulmonary Neuroendocrine Tumors
par: Haoqing CHEN, et autres
Publié: (2021)